20
Views
89
CrossRef citations to date
0
Altmetric
Original Articles

Some Pitfalls in the Evaluation of Screening Programs

&
Pages 412-415 | Received 03 Jan 1969, Accepted 12 May 1969, Published online: 29 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Gunnar Steineck, Hayley Hunt & Jan Adolfsson. (2006) A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncologica 45:4, pages 421-429.
Read now
David L. Streiner. (2003) Diagnosing Tests: Using and Misusing Diagnostic and Screening Tests. Journal of Personality Assessment 81:3, pages 209-219.
Read now
Gunnar Steineck, Philip H. Kass & Anders Ahlbom. (1998) A Comprehensive Clinical Epidemiological Theory Based On the Concept of the Source Person-Time and Four Distinct Study Stages. Acta Oncologica 37:1, pages 15-23.
Read now
ColinB. Begg, Ying Huang & Marianne Berwick. (1996) Separate Estimation of Primary and Secondary Cancer Preventive Impact: Analysis of a Case-Control Study of Skin Self-Examination and Melanoma. Journal of the American Statistical Association 91:436, pages 1381-1387.
Read now

Articles from other publishers (85)

Anssi Auvinen & Anton Barchuk. 2024. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Katy Bell, Jenny Doust, Sharon Sanders, Rachelle Buchbinder, Paul Glasziou, Les Irwig, Mark Jones, Ray Moynihan, Luise Kazda & Alexandra Barratt. (2022) A novel methodological framework was described for detecting and quantifying overdiagnosis. Journal of Clinical Epidemiology 148, pages 146-159.
Crossref
Bernt-Peter Robra. 2021. Ethical Challenges in Cancer Diagnosis and Therapy. Ethical Challenges in Cancer Diagnosis and Therapy 85 104 .
Ahmed Abdulaal, Chanpreet Arhi & Paul Ziprin. (2020) Effect of Health Care Provider Delays on Short-Term Outcomes in Patients With Colorectal Cancer: Multicenter Population-Based Observational Study. Interactive Journal of Medical Research 9:3, pages e15911.
Crossref
Rebecca M. Myerson, Reginald D. Tucker‐Seeley, Dana P. Goldman & Darius N. Lakdawalla. (2020) Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes?. Journal of Policy Analysis and Management 39:3, pages 577-604.
Crossref
J. Rickard Strandberg & Keith Humphreys. (2019) Statistical models of tumour onset and growth for modern breast cancer screening cohorts. Mathematical Biosciences 318, pages 108270.
Crossref
Marc D Ryser, Roman Gulati, Marisa C Eisenberg, Yu Shen, E Shelley Hwang & Ruth B Etzioni. (2019) Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials. American Journal of Epidemiology 188:1, pages 197-205.
Crossref
Anssi Auvinen. 2019. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Gemma Jacklyn, Kevin McGeechan, Nehmat Houssami, Katy Bell, Paul P Glasziou & Alexandra Barratt. (2018) Overdiagnosis due to screening mammography for women aged 40 years and over. Cochrane Database of Systematic Reviews.
Crossref
Jordi Varela. (2017) Sobrediagnóstico: realidades y perspectivas. Medicina Clínica 148:3, pages 118-120.
Crossref
Jordi Varela. (2017) Overdiagnosis: Realities and perspectives. Medicina Clínica (English Edition) 148:3, pages 118-120.
Crossref
Anssi Auvinen & Matti Hakama. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health 389 405 .
Ragnhild Sorum Falk & Solveig Hofvind. (2016) Overdiagnosis in Mammographic Screening because of Competing Risk of Death. Cancer Epidemiology, Biomarkers & Prevention 25:5, pages 759-765.
Crossref
Alexandra L. Barratt & Gemma L. Jacklyn. 2016. Breast Cancer Screening. Breast Cancer Screening 133 164 .
Rositsa G. Koleva-Kolarova, Zhuozhao Zhan, Marcel J.W. Greuter, Talitha L. Feenstra & Geertruida H. De Bock. (2015) Simulation models in population breast cancer screening: A systematic review. The Breast 24:4, pages 354-363.
Crossref
M. Bhutani & O. Landgren. (2014) Bildgebung bei „smoldering“ (asymptomatischem) multiplem MyelomImaging in smoldering (asymptomatic) multiple myeloma. Der Radiologe 54:6, pages 572-581.
Crossref
Lajos Döbrőssy, Attila Kovács, András Budai & Ágnes Cornides. (2012) Gynecological screening or cervical screening? Conflicts between clinical and public health viewpoints. Orvosi Hetilap 153:33, pages 1302-1313.
Crossref
Sue Moss. (2010) Design issues in cancer screening trials. Statistical Methods in Medical Research 19:5, pages 451-461.
Crossref
Yinlu Chen, Guy Brock & Dongfeng Wu. (2010) Estimating key parameters in periodic breast cancer screening—Application to the Canadian National Breast Screening Study data. Cancer Epidemiology 34:4, pages 429-433.
Crossref
George H. Sack. (2009) Comprehensive Outpatient Health Assessment. Medicine 88:5, pages 268-278.
Crossref
Matti Hakama, Michel P. Coleman, Delia-Marina Alexe & Anssi Auvinen. (2008) Cancer screening: Evidence and practice in Europe 2008. European Journal of Cancer 44:10, pages 1404-1413.
Crossref
André N. Vis, Stijn Roemeling, Ardine M.J. Reedijk, Suzie J. Otto & Fritz H. Schröder. (2008) Overall Survival in the Intervention Arm of a Randomized Controlled Screening Trial for Prostate Cancer Compared with a Clinically Diagnosed Cohort. European Urology 53:1, pages 91-98.
Crossref
M. Hakama & A. Auvinen. 2008. International Encyclopedia of Public Health. International Encyclopedia of Public Health 464 480 .
Jason A. Zell & Frank L. Meyskens. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 361 395 .
Michael R. Thompson, Robert J. C. Steele & W. S. Atkin. (2006) Effective Screening for Bowel Cancer: A United Kingdom Perspective. Diseases of the Colon & Rectum 49:6, pages 895-908.
Crossref
Elena B. Elkin, Clifford Hudis, Colin B. Begg & Deborah Schrag. (2005) The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999. Cancer 104:6, pages 1149-1157.
Crossref
B. Schönhofer, J. J. Guo, S. Suchi, D. Köhler & R. Lefering. (2004) The use of APACHE II prognostic system in difficult-to-wean patients after long-term mechanical ventilation. European Journal of Anaesthesiology 21:7, pages 558-565.
Crossref
Paolo Vineis. (2002) History of bias. Sozial- und Präventivmedizin SPM 47:3, pages 156-161.
Crossref
Matthew J McQueen. (2002) Screening for the early detection of disease, the need for evidence. Clinica Chimica Acta 315:1-2, pages 5-15.
Crossref
Lorenzo Dominioni, Andrea Imperatori, Francesca Rovera, Alberto Ochetti, Grazia Torrigiotti & Massimo Paolucci. (2000) Stage I nonsmall cell lung carcinoma. Cancer 89:S11, pages 2334-2344.
Crossref
D. L. Sackett. (1997) A Science for the Art of Consensus. JNCI Journal of the National Cancer Institute 89:14, pages 1003-1005.
Crossref
Sten Friberg. (1997) 5-year cure rate: Yet another myth. Journal of Surgical Oncology 65:2, pages 73-75.
Crossref
Sten Friberg, Adam Taube, Richard Sylvester & Joseph E. Oesterling. (1997) Analysis and presentation. Urology 49:4, pages 54-65.
Crossref
Gunnar Steineck & Jan Adolfsson. (1996) Bias due to observation of different parts of a nonconstant hazard curve over time. Urology 48:1, pages 105-109.
Crossref
Scott A. Hundahl. (1996) Gastric Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations. Surgical Oncology Clinics of North America 5:1, pages 129-144.
Crossref
Sue Moss. 1996. Evaluation of Cancer Screening. Evaluation of Cancer Screening 1 13 .
Kodangudi B. Ramanathan, Faten El-Zeky, Roger Vander Zwaag, Jay M. Sullivan & David M. Mirvis. (1995) Long-term Survival of Patients With Coronary Artery Disease During the 1970s. Chest 107:1, pages 20-27.
Crossref
K. William Harter. 1994. Radiation Therapy in Pediatric Oncology. Radiation Therapy in Pediatric Oncology 305 317 .
William C. Black & H. Gilbert Welch. (1993) Advances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of Therapy. New England Journal of Medicine 328:17, pages 1237-1243.
Crossref
Barnett S. Kramer, John Gohagan, Philip C. Prorok & Charles Smart. (2010) A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 71:S2, pages 589-593.
Crossref
Michael Shwartz. (2016) Validation of a Model of Breast Cancer Screening. Medical Decision Making 12:3, pages 222-228.
Crossref
Charles R. Smart & Kenneth C. Chu. (2006) Staging patterns and early cancer detection. Seminars in Surgical Oncology 8:2, pages 62-72.
Crossref
F V Flynn. (1991) Screening for presymptomatic disease.. Journal of Clinical Pathology 44:7, pages 529-538.
Crossref
Charles R. Smart. (1990) The impact of the U.S. Preventive Services Task Force guidelines on cancer screening. Journal of General Internal Medicine 5:S2, pages S28-S33.
Crossref
M. C. BISHOP. (2008) The Dangers of a Long Urological Waiting List. British Journal of Urology 65:5, pages 433-440.
Crossref
L.J.A. Stalpers, R.B.J. van Vierzen, J.J.A. Brouns, I. Bruaset, J.J. Manni, A.L.M. Verbeek, J.H.J. Ruys & W.A.J. van Daal. (1989) The role of yearly chest radiography in the early detection of lung cancer following oral cancer. International Journal of Oral and Maxillofacial Surgery 18:2, pages 99-103.
Crossref
Daniel E. Ford. (1988) Principles of screening applied to psychiatric disorders. General Hospital Psychiatry 10:3, pages 177-188.
Crossref
Annie J. Sasco. (1988) Lead time and length bias in case-control studies for the evaluation of screening. Journal of Clinical Epidemiology 41:1, pages 103-104.
Crossref
Julia E. Connelly. 1988. Prevention in Clinical Practice. Prevention in Clinical Practice 419 434 .
Michael J. Barry, Albert G. Mulley & James M. Richter. (1987) Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer. Gastroenterology 93:2, pages 301-310.
Crossref
Curtis Mettlin & Nachimuthu Natarajan. (1987) End results for urologic cancers. Trends and interhospital differences. Cancer 60:S3, pages 474-479.
Crossref
Albert G. Mulley. (1987) Screening Tests for the Healthy Patient. Medical Clinics of North America 71:4, pages 625-637.
Crossref
B. A. Stoll. 1987. Pointers to Cancer Prognosis. Pointers to Cancer Prognosis 195 229 .
Albert G. Mulley. (1986) Screening the Healthy Subject. Clinics in Laboratory Medicine 6:2, pages 241-252.
Crossref
Curtis Mettlin & K. Michael Cummings. (2006) The current status of early detection and screening for colorectal cancer. Seminars in Surgical Oncology 2:4, pages 215-224.
Crossref
Petr Skrabanek, N.E. Day, L. Tabár, G. Fagerberg & A.D. Hibberd. (1985) BREAST CANCER SCREENING. The Lancet 326:8446, pages 94-95.
Crossref
Alvan R. Feinstein, Daniel M. Sosin & Carolyn K. Wells. (1985) The Will Rogers Phenomenon. New England Journal of Medicine 312:25, pages 1604-1608.
Crossref
I. Andersson, L. Janzon & B.F. Sigfússon. (1985) Mammographic breast cancer screening —a randomized trial in Malmö, Sweden. Maturitas 7:1, pages 21-29.
Crossref
J. G. Brecht. 1985. Methodical Problems in Early Detection Programmes. Methodical Problems in Early Detection Programmes 110 115 .
John C. BailarIIIIII, Thomas A. Louis, Philip W. Lavori & Marcia Polansky. (1984) A Classification for Biomedical Research Reports. New England Journal of Medicine 311:23, pages 1482-1487.
Crossref
Michael Shwartz, Joseph S. Pliskin, Hans‐Göran Gröndahl & Joseph Boffa. (2006) Study design to reduce biases in estimating the percentage of carious lesions that do not progress within a time period. Community Dentistry and Oral Epidemiology 12:2, pages 109-113.
Crossref
S. A. Feig. 1984. Early Detection of Breast Cancer. Early Detection of Breast Cancer 11 27 .
J. D. F. Habbema, G. J. Van Oortmarssen & D. J. Van Putten. (2006) An analysis of survival differences between clinically and screen‐detected cancer patients. Statistics in Medicine 2:2, pages 279-285.
Crossref
Neil Dubin. (2016) Predicting the benefit of screening for disease. Journal of Applied Probability 18:2, pages 348-360.
Crossref
Neil Dubin. (2016) Predicting the benefit of screening for disease. Journal of Applied Probability 18:02, pages 348-360.
Crossref
I. Andersson. (2016) Radiographic Screening for Breast Carcinoma. Acta Radiologica. Diagnosis 22:3A, pages 227-233.
Crossref
I. Andersson. (2016) Radiographic Screening for Breast Carcinoma. Acta Radiologica. Diagnosis 22:2, pages 185-194.
Crossref
Michael Shwartz. (1980) Estimates of lead time and length bias in a breast cancer screening program. Cancer 46:4, pages 844-851.
Crossref
Ralph S. Freedman, James Bowen, Jay Herson, J.Taylor Wharton & Felix N. Rutledge. (1980) Tumor antigenicity and the immune system in gynecological cancer: A review. Gynecologic Oncology 9:1, pages 43-62.
Crossref
Walter O. Spitzer & David Sackett. (1980) Editorial Research priorities on prevention of chronic diseases. Journal of Chronic Diseases 33:8, pages 459-463.
Crossref
Michael Shwartz. (1978) An analysis of the benefits of serial screening for breast cancer based upon a mathematical model of the disease. Cancer 41:4, pages 1550-1564.
Crossref
Yuichi Nakamura, Moriyuki Takeshita, Yasuo Hirota, Kazuo Ueda, Tsuneyoshi Yao, Takeshi Kohzuki, Teruo Omae & Takesumi Yoshimura. (1977) An evaluation of gastric cancer screening program in Hisayana, Japan. Gastroenterologia Japonica 12:6, pages 427-434.
Crossref
Bengt Lundgren. (1977) Observations on growth rate of breast carcinomas and its possible implications for lead time. Cancer 40:4, pages 1722-1725.
Crossref
John C. Bailar. (1977) Screening for early breast cancer: Pros and cons. Cancer 39:6, pages 2783-2795.
Crossref
Maureen Henderson. (1976) Validity of screening. Cancer 37:S1, pages 573-581.
Crossref
DavidL Sackett & WalterW Holland. (1975) CONTROVERSY IN THE DETECTION OF DISEASE. The Lancet 306:7930, pages 357-359.
Crossref
Th. Abelin. (1975) Die Evaluation von VorsorgeprogrammenL'évaluation des programmes préventitsThe evaluation of preventive programs. Sozial- und Präventivmedizin SPM 20:3-4, pages 115-119.
Crossref
W.W. Holland. (1974) TAKING STOCK. The Lancet 304:7895, pages 1494-1497.
Crossref
Joseph P. NewhouseCharles E. PhelpsWilliam B. Schwartz. (1974) Policy Options and the Impact of National Health Insurance. New England Journal of Medicine 290:24, pages 1345-1359.
Crossref
Knut Gjesdal & Johan H. Strømme. (2018) Multiphasic Screening Programme for Somatic Diseases Among Elderly Long-Term Psychiatric Patients. British Journal of Psychiatry 124:583, pages 564-572.
Crossref
Abraham M. Lilienfeld. (1974) Some limitations and problems of screening for cancer. Cancer 33:S6, pages 1720-1724.
Crossref
Ralph S. PaffenbargerJr.Jr.. (2006) Value in the early diagnosis of cancer. Cancer 33:S6, pages 1712-1719.
Crossref
David Schottenfeld. (1972) Patient risk factors and the detection of early cancer. Preventive Medicine 1:3, pages 335-351.
Crossref
Max Wilson, Jocelyn Chamberlain & A.L Cochrane. (1971) SCREENING FOR CERVICAL CANCER. The Lancet 297:7693, pages 297-298.
Crossref
Katy Bell, Jenny Doust, Sharon Sanders, Rachelle Buchbinder, Paul Glasziou, Les Irwig, Mark Jones, Ray Moynihan, Luise Kazda & Alexandra Barratt. (2022) A Novel Methodological Framework for Detecting and Quantifying Overdiagnosis. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.